201 related articles for article (PubMed ID: 19836381)
1. Endoradiotherapy in cancer treatment--basic concepts and future trends.
Zoller F; Eisenhut M; Haberkorn U; Mier W
Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy of prostate cancer.
Smith-Jones PM
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):297-304. PubMed ID: 15640793
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry in Peptide radionuclide receptor therapy: a review.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy with alpha-particle emitting radionuclides.
Zalutsky MR; Pozzi OR
Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
[TBL] [Abstract][Full Text] [Related]
5. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
DeNardo GL
Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
[TBL] [Abstract][Full Text] [Related]
6. The promise of targeted {alpha}-particle therapy.
Mulford DA; Scheinberg DA; Jurcic JG
J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
[TBL] [Abstract][Full Text] [Related]
7. Biotechnology techniques for the development of new tumor specific peptides.
Marr A; Markert A; Altmann A; Askoxylakis V; Haberkorn U
Methods; 2011 Nov; 55(3):215-22. PubMed ID: 21640826
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
Ferro-Flores G; Arteaga de Murphy C
Adv Drug Deliv Rev; 2008 Sep; 60(12):1389-401. PubMed ID: 18547675
[TBL] [Abstract][Full Text] [Related]
9. Current status of therapy of solid tumors.
Jhanwar YS; Divgi C
J Nucl Med; 2005 Jan; 46 Suppl 1():141S-50S. PubMed ID: 15653662
[TBL] [Abstract][Full Text] [Related]
10. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
[TBL] [Abstract][Full Text] [Related]
11. Radiotargeted gene therapy.
Buchsbaum DJ; Chaudhuri TR; Zinn KR
J Nucl Med; 2005 Jan; 46 Suppl 1():179S-86S. PubMed ID: 15653667
[TBL] [Abstract][Full Text] [Related]
12. Candidates for peptide receptor radiotherapy today and in the future.
Reubi JC; Mäcke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
Karagiannis TC
Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
[TBL] [Abstract][Full Text] [Related]
14. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
Steiner M; Neri D
Clin Cancer Res; 2011 Oct; 17(20):6406-16. PubMed ID: 22003068
[TBL] [Abstract][Full Text] [Related]
15. Systemic targeted radionuclide therapy: potential new areas.
Wong JY
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S74-82. PubMed ID: 16979445
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
18. Antibody-based targeted radiation to pediatric tumors.
Modak S; Cheung NK
J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
[TBL] [Abstract][Full Text] [Related]
19. Time-dose-fractionation in radioimmunotherapy: implications for selecting radionuclides.
Rao DV; Howell RW
J Nucl Med; 1993 Oct; 34(10):1801-10. PubMed ID: 8410301
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experience.
Cremonesi M; Ferrari M; Chinol M; Bartolomei M; Stabin MG; Sacco E; Fiorenza M; Tosi G; Paganelli G
Q J Nucl Med; 2000 Dec; 44(4):325-32. PubMed ID: 11302260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
